ImStem Biotechnology
PrivateLast Round
Pre Seed
Aug 23, 2013
Total Funding Raised
$1.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ImStem Biotechnology operates in Healthcare & Life Sciences and is based in Farmington, Connecticut. Its latest recorded funding round was a Pre Seed round in August 2013.
ImStem Biotechnology is a biopharmaceutical company that develops human embryonic stem cell-derived mesenchymal stem cell therapies for the treatment of autoimmune, degenerative, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImStem Biotechnology Comparables
Compare ImStem Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ernexa Therapeutics Inc. | 78% | |
| Brainstorm Cell Therapeutics Inc. | 77% | |
| Serina Therapeutics Inc | 76% |
For institutional investors. Book with your work email.
ImStem Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Aug 23, 2013 | ||||
| Grant | Jun 11, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ImStem Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 1420% MoM.
- Jan 19, 2026
Monthly visitors grew 107% MoM.
For institutional investors. Book with your work email.
ImStem Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImStem Biotechnology's valuation, stock price, and market status.
Is ImStem Biotechnology a public or private company?
ImStem Biotechnology is a private company.
What is the current stock price of ImStem Biotechnology?
ImStem Biotechnology is a private company, so its shares have no public market price. Caplight tracks ImStem Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImStem Biotechnology worth (valuation)?
Valuation information for ImStem Biotechnology is not publicly available.
Can I buy ImStem Biotechnology stock?
ImStem Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImStem Biotechnology's last funding round?
ImStem Biotechnology's most recent funding round was Pre Seed on August 23, 2013.
Who are the main investors in ImStem Biotechnology?
Key investors in ImStem Biotechnology include Connecticut Innovations.
Will ImStem Biotechnology IPO soon?
No public IPO plans have been announced for ImStem Biotechnology.
How can I track ImStem Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in ImStem Biotechnology's shares on secondary markets.